drugset / Trial / NCT02139007

Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study

NCT02139007

Phase 4 Completed 27 enrolled University of Alabama at Birmingham
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a pilot study evaluating the recruitment strategies for sites and patients, data collection instruments, follow-up procedures, administrative processes, and the proposed management strategy for the future large scale national trial.

Timeline

Start
2014-06
Primary completion
2016-06
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alendronic Acid Small molecule

Indications